Bovista 30C (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Bovista 30C drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Bovista
SUBSTANCE NAME: LYCOPERDON UTRIFORME FRUITING BODY
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-06-18
END MARKETING DATE: 0000-00-00


Bovista 30C HUMAN OTC DRUG Details:

Item DescriptionBovista 30C from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/1)
START MARKETING DATE: 2015-06-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-1093_18c70ca5-56cd-1978-e054-00144ff8d46c
PRODUCT NDC: 69152-1093
APPLICATION NUMBER:

Other LYCOPERDON UTRIFORME FRUITING BODY Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Paramesh Banerji Life Sciences LLCBovista 200C
Washington Homeopathic ProductsBovista